E9D-32566-31840
4 vaccinations
5 coded responses
22 check-ins
5 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 275 / NC
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
D6U-45355-15215
Adult relative or friend · Female · 2021-10-01
Timeline
-
2021-02-01
Dose 1 — Pfizer-BioNTech
-
2021-02-22
Dose 2 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-03-27
Survey response — day 28, dose 2MedDRA: Contusion, Herpes zoster, Office visit, Urinary tract disorder — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 0n 3/11/2021, I started feeling initial SHINGLES symptoms. Treated by PCP starting on 3/18/2021. Despite prescribed anti-viral and antibiotics, on 3/27/2021, still dealing with skin bruises and urinary issues.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-27
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-31
- 2021-04-05
- 2021-05-24
- 2021-08-23
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-05
- 2021-10-06
- 2021-10-15
- 2021-10-22
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2021-12-29
- 2022-03-11
-
2022-03-22
Call successfulDoes not wish to fill out VAERS report
- 2022-04-01
-
2022-04-16
Dose 4 — Pfizer-BioNTechCo-administered: Shingles
-
2022-05-15
Survey response — day 28, dose 4MedDRA: Cough, Fatigue, Lacrimation increased, Rhinorrhoea, Sneezing — Feeling: FairFree text: Runny nose, watery eyes, fatigue, sneezing, occasional coughingMedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Survey response — day 35, dose 4MedDRA: Cough, Headache, Lacrimation increased, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose, watery eyes, headache, sneezing, cough and throat congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-28
Survey response — day 42, dose 4MedDRA: COVID-19, Cough, Headache, Lacrimation increased, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to do your normal daily activitiesFree text: COVID-19 - Runny nose, watery eyes, sneezing, periodic coughing, mild headache.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-16
-
2022-10-17
Survey response — 6 months, dose 4MedDRA: Neuropathy peripheral — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ulnar neuropathyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-17
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-04-16 | Pfizer-BioNTech | Shingles |
Call center
2 call center cases
1 successful · 1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — day 28, dose 2
Symptoms: 0n 3/11/2021, I started feeling initial SHINGLES symptoms. Treated by PCP starting on 3/18/2021. Despite prescribed anti-viral and antibiotics, on 3/27/2021, still dealing with skin bruises and urinary issues.
Release 11 — day 28, dose 4
Symptoms: Runny nose, watery eyes, fatigue, sneezing, occasional coughing
Release 11 — day 35, dose 4
Symptoms: Runny nose, watery eyes, headache, sneezing, cough and throat congestion.
Release 11 — day 42, dose 4
Symptoms: COVID-19 - Runny nose, watery eyes, sneezing, periodic coughing, mild headache.
Release 12 — 6 months, dose 4
Symptoms: Ulnar neuropathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Contusion | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Herpes zoster | ✓ | ✓ | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Neuropathy peripheral | · | · | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Urinary tract disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release